Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-24-012926
Filing Date
2024-09-20
Accepted
2024-09-20 16:20:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20240919xdefa14a.htm DEFA14A 28093
2 GRAPHIC tmb-20240919xdefa14a006.jpg GRAPHIC 35357
  Complete submission text file 0001558370-24-012926.txt   78169
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-36410 | Film No.: 241313647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)